Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tolperisone - Sanochemia

Drug Profile

Tolperisone - Sanochemia

Alternative Names: Agileo; AV-650; Instant release (IR) tolperisone tablets - Sanochemia; SPH-3047; Sustained release tolperisone tablets - Sanochemia; Tolcare; Viveo

Latest Information Update: 19 Sep 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Sanochemia Pharmazeutika
  • Developer Neurana Pharmaceuticals; Sanochemia Pharmazeutika
  • Class Analgesics; Antispasmodics; Antispastics; Muscle relaxants; Propiophenones; Pyridines; Small molecules
  • Mechanism of Action Neuromuscular blocking agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Muscle hypertonia; Muscle spasticity
  • No development reported Spasm

Most Recent Events

  • 07 May 2018 Neurana Pharmaceuticals plans a phase II trial for acute, painful neuromuscular spasms of neck and back in late 2018
  • 26 Sep 2017 Neurana Pharmaceuticals completes enrolment in a clinical trial for Muscle spasticity (In volunteers) in USA
  • 26 Jul 2017 Neurana Pharmaceuticals initiates a clinical trial for Muscle spasticty (In volunteers) in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top